Moreover, the modulatory effect of Prpf19 and Exoc7 was further confirmed in SCA3 Drosophila disease models in vivo (Figs. 7, 8 and Supplementary Fig. 6). This evidence concerns the gene ATXN3 and glycogen storage disease VI.